The Journal. · Friday, August 28, 2026
Moderna is developing a personalized cancer vaccine that aims to train the immune system to fight tumors. Early results from a Phase 1 trial for melanoma have shown promising signs of efficacy.
“Moderna is developing a personalized cancer vaccine that it hopes will train the immune system to destroy cancer.”
“They've been testing out a personalized cancer vaccine for melanoma, a type of skin cancer.”
“The vaccine showed a lot of promise in these early trials, with patients in the study seeing a significant reduction in their tumors.”